Purchase Order 75H71124P00149

Award Date 2/26/24
Potential Completion Date 3/29/24
Potential Value $20K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lawton, OK 73501, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings, has received a $46,457.76 delivery order from the Department of Health and Human Services Indian Health Service (IHS) for laboratory equipment and supplies. The firm fixed price order was issued against Medtox's Law Enforcement & Security Services (FSS-84) Multiple Award Schedule contract with the General Services Administration, with no set-aside designation. The products will be delivered to the IHS...
This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a division of the Department of Health and Human Services, to Medtox Diagnostics, Inc., a manufacturer of laboratory testing products and services. The contract, valued at $27,500.60, is for the delivery of drugs of abuse testing supplies to support direct patient care activities and drug screening for Native American populations served by IHS facilities. The award has no set-aside designation, indicating...
This federal contract award to Medtox Diagnostics, Inc., a subsidiary of Laboratory Corporation of America Holdings, is a Blanket Purchase Agreement (BPA) to procure miscellaneous laboratory supplies for the Indian Health Service (IHS), a division of the Department of Health and Human Services. The $13,184.87 firm fixed price contract has a completion date of January 31, 2023. Medtox Diagnostics, a manufacturer of laboratory testing products and services, primarily provides drugs of abuse...
This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Medtox Diagnostics, Inc., a subsidiary of Laboratory Corporation of America Holdings (LabCorp). The contract is for urine drug screening and confirmatory testing services to support the IHS's healthcare operations, with a ceiling value of $156,528.79 and a period of performance through September 30, 2025. The contract was competitively...
This is a firm fixed-price purchase order awarded to Medtox Diagnostics, Inc., a manufacturer of laboratory testing products and services, by the Indian Health Service (IHS), a division of the Department of Health and Human Services. The contract has a ceiling value of $25,000.00 and an ultimate completion date of December 31, 2025. The contract is for the provision of laboratory supplies and testing supplies to support the clinical testing, direct patient care activities, and drug screening...
Medtox Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, was awarded a $10,133.10 firm fixed price delivery order against the Multiple Award Schedule contract vehicle. The contract calls for Medtox to provide drug profiles and supplies in support of the Lawton Indian Hospital, part of the Indian Health Service within the Department of Health and Human Services. No set-aside designation was used for this award. Performance will occur in Burlington, North Carolina as...
This federal contract award, valued at $23,853.17, was issued by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The contract is for the provision of laboratory testing supplies for the IHS laboratory department. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Medtox Laboratories Inc. holds a...
This federal contract award, valued at $19,779.60, was issued by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The contract is for the purchase of 12 drug screening panels and does not have a set-aside designation, indicating open competition. Medtox Laboratories holds a Multiple Award Schedule (MAS) contract with the General Services...
The Department of Health and Human Services Indian Health Service awarded a $20,078.10 firm fixed price delivery order against the Multiple Award Schedule contract vehicle to Medtox Laboratories, Inc. for drug screen services. Medtox Laboratories, Inc. is a division of Laboratory Corporation of America Holdings and will perform the drug screens in Lawton, Oklahoma by the July 31, 2021 completion date. No set-aside designation was used for this contract award to support the Indian Health...
The Department of Health and Human Services Indian Health Service awarded a $10,182.21 delivery order contract to Medtox Laboratories, Inc. for drug profile and supplies. Medtox Laboratories, Inc. will deliver the requested products and services under the Multiple Award Schedule contract vehicle. The contract has no set-aside designation and requires completion by December 5, 2022. Performance will take place in Burlington, North Carolina. Medtox Laboratories, Inc. is a division of Laboratory...

Medtox Diagnostics, Inc. was awarded a $19,894.20 firm fixed price purchase order by the Department of Health and Human Services Indian Health Service to provide laboratory testing products for the Lawton, Oklahoma IHS facility. As a prime contractor and manufacturer, Medtox will deliver urine drug screening tests and other miscellaneous laboratory supplies to support routine clinical testing services. No set-aside designation was used for this award, which is to be completed by March 29, 2024. Medtox has a history of providing diagnostic products for the IHS through purchase orders and blanket purchase agreements, totaling over $500,000 since 2019. The company is a subsidiary of Laboratory Corporation of America Holdings, a leading life sciences firm that routinely supports federal healthcare agencies with specialized laboratory testing.

Generated 2/28/24, 9:03 AM